Search results
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against bluebird bio,...
Morningstar· 5 days agoPomerantz LLP announces that a class action lawsuit has been filed against bluebird bio, Inc. (“bluebird” or the “Company”) (NASDAQ: BLUE). Such investors are advised to contact Danielle Peyton ...
Jazz Pharmaceuticals (JAZZ) Set to Announce Earnings on Wednesday
ETF DAILY NEWS· 5 days agoJazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) is scheduled to be issuing its quarterly earnings data after the market closes on Wednesday, May 1st. Analysts expect the company to announce ...
Eagles sweep Panthers in county rematch
The Herald Bulletin, Anderson, Ind. via Yahoo Sports· 4 days agoApr. 24—ELWOOD — At least it was dry the second time around. Less than two weeks after barely finishing their Madison County first-round match on a chilly and damp evening, Frankton returned ...
Vor Biopharma’s (VOR) “Outperform” Rating Reiterated at Wedbush
ETF DAILY NEWS· 3 days agoWedbush reissued their outperform rating on shares of Vor Biopharma (NYSE:VOR – Free Report) in a research report released on Tuesday, Benzinga reports. Wedbush currently has a $11.00 price ...
BioLineRx (NASDAQ:BLRX) Upgraded by StockNews.com to Sell
ETF DAILY NEWS· 5 days agoStockNews.com upgraded shares of BioLineRx (NASDAQ:BLRX – Free Report) to a sell rating in a research note published on Tuesday morning. Separately, HC Wainwright restated a buy rating and issued ...
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Sold by Vontobel Holding Ltd.
ETF DAILY NEWS· 6 days agoVontobel Holding Ltd. lessened its stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 6.0% during the fourth quarter, according to the company in its most recent 13F filing with ...
Kura Oncology, Inc. (NASDAQ:KURA) Stock Holdings Lessened by Mirae Asset Global Investments Co. Ltd.
ETF DAILY NEWS· 3 days agoMirae Asset Global Investments Co. Ltd. lessened its holdings in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 5.7% in the fourth quarter, according to the company in its most ...
Kura Oncology (NASDAQ:KURA) Stock Rating Reaffirmed by HC Wainwright
ETF DAILY NEWS· 5 days agoKura Oncology (NASDAQ:KURA – Get Free Report)‘s stock had its “buy” rating restated by equities research analysts at HC Wainwright in a research note issued on Monday, Benzinga reports. HC Wainwright ...
How Big Pharma Is Taking A Page Out Of Novartis' Playbook
Investor's Business Daily· 4 days agoNovartis (NVS) blazed a trail for treating cancer with targeted radiopharmaceuticals, a treatment that sends radiation directly to cancer cells. Novartis' prostate cancer drug, Pluvicto, which ...
